Figure 1. Aggregate Analysis of Mutation Calls.
(A) Co-occurrence of mutations in melanoma cell lines including SNVs, CNV calls from SNP array, and both. (B) Co-occurrence of mutations in metastatic cutaneous melanoma showing KIT mutations in BRAF and NRAS wild type lines. (C) Putative somatic mutation rates in melanoma cell lines and (D) putative somatic mutations in tumors.